Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

Genesis HealthCare (NYSE: GEN) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.Genesis HealthCare reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance